ERBB2 and breast cancer: As mentioned above, our study provided relevant information also on the role of BCG in the management of T1G3 BC as the two patients populations (treated and not-treated with BCG) were comparable not only for stage and grade (T1G3) but also for “traditional” and “novel” prognostic factors such as HER-2 status.